A Comparative Study of Triple-Layered Aceclofenac Matrix Tablets Formulated using Xanthan Gum and Guar Gum

DOI:

https://doi.org/10.37285/ijpsn.2012.5.1.5

Authors

  • Mona Semalty
  • T Bisht
  • A Semalty

Abstract

The aim of the present study was to develop sustained release, multilayered-matrix tablet of aceclofenac using natural polymers-guar gum (GG) and xanthan gum (XG) as carrier for core matrix and hydroxyl propylmethyl cellulose (HPMC K-15M), sodium carboxymethylcellulose (NaCMC) and ethyl cellulose (EC) and polyvinylpyrrolidone (PVP-K30) for preparing bottom and top layers. The formulated tablets were evaluated for uniformity of weight, drug content, friability, hardness, thickness, swelling index and in vitro drug release. The physicochemical properties of tablets were found within the limits. The physiochemical investigation showed that aceclofenac matrix tablet prepared with xanthan gum showed better dissolution profile as compared to that of guar gum. Matrix tablets of xanthan gum with 6% W/V xanthan gum (MTX1) showed the highest percent drug release (88.98%), while matrix tablets of guar gum with 6% W/V guar gum (MTG1) showed the highest percent drug release (73.89%) at the end of 8 hours in pH 6.8 phosphate buffer. Among the matrix tablet of xanthan gum MTX4 (with 24% W/V of xanthan) showed the lowest percent drug release (49.6%) and while among the guar gum tablets MTG4  (with 24% W/V of guar gum) showed the lowest percent drug release (48.65%) at the end of 8 hours. It was concluded that increasing the concentration of gum from 6% W/V to 24% W/V in the formulation decreased the amount of drug release from the tablet. The xanthan gum based matrix tablets of aceclofenac were found to be superior to that of guar gum matrix tablets for potential therapeutic uses. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Aceclofenac, matrix tablets, sustained release, xanthan gum, guar gum

Downloads

Published

2012-05-31

How to Cite

1.
Semalty M, Bisht T, Semalty A. A Comparative Study of Triple-Layered Aceclofenac Matrix Tablets Formulated using Xanthan Gum and Guar Gum. Scopus Indexed [Internet]. 2012 May 31 [cited 2024 May 18];5(1):1621-6. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/563

Issue

Vol. 5 No. 1 (2012): April-June 2012

Section

Research Articles
Crossref
Scopus
Google Scholar
Europe PMC

References

Conte U and Maggi L (1996). Modulation of the dissolution profiles from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials 17: 889–896.

Dhopeshwarkar V and Zatj JL (1993). Evaluation of Xanthan Gum in the Preparation of Sustained Release Matrix Tablets, Drug Develop Ind Pharm 19: 999-1017.

El-Nabarawi MA (2005). Modulation of tenoxicam release from hydrophilic matrix: Modulator membrane versus rate-controlling membrane. Chem Pharm Bull 53:1083–7.

Gohel MC and Bariya SH (2009). Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum. AAPS PharmSciTech 10(2): 624–630.

Gowda DV, Girish B and Shivakumar H (2008). Preparation and evaluation of carnauba wax microspheres’ loaded with aceclofenac for controlled release. Indian J Pharm Educ Res 42: 329-336.

Krishnaiah YSR, Karthikeyan RS and Satyanarayana V (2002). A three layered guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartarate. Int J Pharm 241: 353-66.

Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN and Barreto JC (1995). Non steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nature Med 11:154-58.

Maggi L, Bruni R and Conte U (2000). High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. Int J Pharm 195: 229–38.

Rasul A, Iqbal M, Murtaza G, Waqas MK, Hanif M, Khan SA and Bhatti NS (2010). Design, development and in vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth. Acta Poloniae Pharmaceutica - Drug Research 67: 517-522.

Salsa T, Veiga F and Pinna ME (1997). Oral controlled release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Develop. Ind. Pharm. 23: 929-38.

Shajahan A and Poddar SS (2004). A flexible technology for modified release of drugs: multi layered tablets. J Control Rel 97: 393–405.

Siahi MR, Jalali MB, Monajjemzadeh F, Ghaffari F and Azarmi S (2005). Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release. AAPS PharmSciTech 6(4):EE626–EE32.

Varshosaz J, Tavakoli N and Kheirolahi F (2006). Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm Sci Tech 7(1):E24.

Verhoeven E, Vervaet C and Remon JP (2006). Xanthan gum to tailor drug release of sustained ethyl cellulose mini matrices prepared via hot melt extrusions- in vitro-in vivo evaluation. Euro J Pharm Biopharm 63: 320-330.

Yeole PG, Galgatte UC, Babla IB and Nakhat PD (2006). Design and evaluation of xanthan gum based sustained release matrix tablet of diclofenac sodium. Indian J Pharm Sci 68: 185-189.